People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The task force determines which preventive services insurers must cover at no cost to patients.

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...

Just diagnosed with HIV? We have answers to your most commonly-asked questions, including what it means to be "undetectable." ...

The European Medicines Agency’s CHMP has recommended approval of Gilead Sciences’ lenacapavir, a twice-yearly injection for preventing HIV infection.

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

The Food and Drugs Authority (FDA) Ghana also stepped in, issuing a disclaimer confirming that no clinical trial on COA-72 for HIV treatment had been approved, further validating COARMLC’s position.

The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...